The largest database of trusted experimental protocols

3 protocols using khyg 1

1

MUC1-Expressing Tumor Cell Lines for Preclinical Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell culture reagents were purchased from Biowest and Serana. Tumor cell lines ZR-75-1, MCF-7, HSC-4, CaoV-3 and T-47D as well as the human NK cell line KHYG-1 and murine T cell line CTLL-2 were obtained from DSMZ or ATCC and cultured in the respective recommended medium under standard conditions. KHYG-1 and CTLL-2 were cultured in presence of 10 ng/mL IL-2 (PeproTech, Rocky Hill, NJ, USA).
For in vivo studies, the murine tumor cell lines B16.F10 and CT26.wt (ATCC) were stably transfected by electroporation (Amaxa) with a plasmid coding for human MUC1 (40 tandem repeats) and confirmed for TA-MUC1 expression in vitro and in vivo in mice by flow cytometry and immunohistochemistry using GT-00A. Cells were cultured in standard medium +100 nM methotrexate (Hexal, Holzkirchen, Germany) as selection pressure. For the metastasis model, hMUC1-B16.F10 cells were further transduced to stably express firefly luciferase (110 RLU/cell) enabling detection of metastasis. Origin, TA-MUC1 and IL-15R expression status of cell lines are indicated in Table S1.
Peripheral blood mononuclear cells (PBMCs) were prepared from commercially available buffy coats (DRK Berlin) or leukapheresates (Charité Berlin) of healthy donors by Biocoll separation (Biochrom, Cambridge, UK) and density gradient centrifugation. PBMCs from leukapheresate products were stored frozen in liquid nitrogen.
+ Open protocol
+ Expand
2

Characterization of Cell Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T (RRID:CVCL_4401) and Rat-1 (RRID:CVCL_0492) were obtained from Takara Bio (Kusatsu, Japan) and RIKEN BRC (Tsukuba Japan), respectively. Expi293 (RRID:CVCL_D615) and CHO/G16 were obtained from Thermo Fisher Scientific. KHYG-1 (RRID:CVCL_2976) and Ramos (RRID:CVCL_0597) were obtained from JCRB Cell Bank. The 293c18 (RRID:CVCL_6974), CT26.WT (RRID:CVCL_7256), and EMT6 (RRID:CVCL_1923) cell lines were obtained from ATCC. Colon26 (RRID:CVCL_0240) was obtained from Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). HEK293T and Rat-1 were cultured in Dulbecco's Modified Eagle Medium (DMEM) with 2 mmol/L L-glutamine containing 10% fetal bovine serum (FBS). Ramos and KHYG-1 cells were cultured in an RPMI-1640 medium with 2 mmol/L L-glutamine containing 10% FBS and MEM. In KHYG-1 cells, 100 units/mL of recombinant human IL2 (PeproTech) were added to the culture medium. CT26.WT, Colon26, and EMT6 were cultured in DMEM with 10% FBS. The method for the generation of gene-transfected cells is described in the Supplementary Materials. All cell lines were used within 10 passages after thawing. Cell authentication was routinely performed by comparing cell morphology and growth properties with suppliers’ data. The cells were not tested for mycoplasma contamination.
+ Open protocol
+ Expand
3

Myeloma Cell Lines and Patient Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines MM1S, JJN3, H929, K562, and NK-92 were from American Type Culture Collection (ATCC). KHYG-1 was kindly provided by Dr. Armand Keating (University of Toronto). All cell lines except NK-92 were cultured in RPMI-1640 supplemented with 10% heat-inactivated FBS (Sigma Aldrich), 100 IU/mL of penicillin, and 100 µg/mL of streptomycin. NK-92 cells were cultured in X-VIVO 10 media (Lonza) supplemented with 20% human AB serum (Sigma) and 500 IU/mL of interleukin (IL) 2. KHYG-1 cells were supplemented with 100 IU/mL of IL-2 (Peprotech). Fresh bone marrow (BM) was obtained from patients with MM after informed consent. Mononuclear cells (MNCs) were obtained from BM aspirates (BMAs) after density gradient centrifugation with Ficoll-Paque. CD138+ MM cells were isolated by magnetic bead-based positive selection (StemCell Technologies). MNC, CD138-, and CD138+ fractions from BMAs supplied from patients with MM were provided by the Blood Cancer Biobank Ireland.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!